Screening for colorectal cancer and precancerous lesions includes stool tests, carcinoembryonic antigen (CEA), colonoscopy, colonography, computed tomography (CT), and double-contrast barium enema (DCBE) [3]. This evidence concerns the gene CEACAM5 and colorectal cancer.